Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape

Johnson & Johnson Soars: Beating Q3 Expectations and Raising Full-Year Outlook

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

Wall Street Reacts: Top Stock Moves and Analyst Insights Shaping Thursday's Market

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

Unleash the Alpha: Why This October Dog of the Dow is a Top Dividend Pick

Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

IG Acquisition Corp. (IGAC): The Power of a Vanishing Discount Fueling Stellar Returns

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Healthcare Shorts Take a Breather, But Moderna Remains Under the Microscope

Kenvue Explores 'Learned Intermediary' Defense Amidst Thousands of Tylenol-Autism Lawsuits

Controversial Critic Returns: Dr. Vinay Prasad Reassumes Key FDA Role

A New Horizon in Bladder Cancer Treatment: J&J's Balversa Secures Full FDA Approval

Game Changer: FDA Approves Johnson & Johnson's TAR-200 for High-Risk Bladder Cancer

Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave

Legend Biotech Explores Strategic Second Listing Beyond US Shores

Carlsmed's Personalized Spine Implants Revolutionize Care with Landmark Reimbursement Approval

First RSV shots, groundbreaking gene therapy among 2024 drugs to watch